首页> 外文期刊>Danishgah-i Ulum-i Pizishki va Khadamat-i Bihdashti-Darmani Shahid Sadugi Yazd. Majallah >Effect of Subcutaneous Enoxaparin Injection Duration on Site-Pain Intensity in Acute Coronary Syndrome Patients Hospitalized in CCU Afshar Hospital, Yazd, 2011
【24h】

Effect of Subcutaneous Enoxaparin Injection Duration on Site-Pain Intensity in Acute Coronary Syndrome Patients Hospitalized in CCU Afshar Hospital, Yazd, 2011

机译:皮下注射依诺肝素注射时间对急性冠状动脉综合症住院患者的痛觉强度的影响,亚兹德,2011年

获取原文
           

摘要

Introduction: Enoxaparin is widely used in acute coronary syndrome patients to prevent progression of coronary artery disease. Pain of injection site is the unpleasant result of subcutaneous Enoxaparin injection which causes the patient physical discomfort. One of the nurses’ tasks is applying techniques which cause the reduction of damage to the patient. This clinical trial study investigates the effect of injection duration of subcutaneous Enoxaparin on site-pain intensity in acute coronary syndrome patients hospitalized in Coronary Care Unit.Methods: Seventy 30-75 year-old acute coronary syndrome patients hospitalized in coronary care unit were selected randomly. Enoxaparin was injected randomly to either right or left side of abdomen with a 12-hour interval during 10 seconds and 30 seconds. In order to assess the site pain intensity, visual analog scale (VAS) was used before and immediately after injection. Data analysis was done by descriptive statistics and non-parametric tests. Results: Results indicated that mean of pain intensity before 10 seconds is 0.78±4.93, after 10 seconds is 15.95±19.43 before 30 seconds is 0.64±3.79 and after 30 seconds is 8.08±12.91. Thus, 30 second duration of injection resulted in significant less pain intensity (P=0.000). There was no relationship between pain and sex, age and educational level.Conclusion: According to the study results, increasing injection duration of subcutaneous Enoxaparin to 30 seconds reduces the site pain intensity.
机译:简介:依诺肝素广泛用于急性冠状动脉综合征患者,以预防冠状动脉疾病的进展。注射部位疼痛是依诺肝素皮下注射的不愉快结果,其导致患者身体不适。护士的任务之一是应用可以减少对患者伤害的技术。本临床试验研究了依诺肝素皮下注射持续时间对在冠心病科住院的急性冠脉综合征患者的部位疼痛强度的影响。方法:随机选择在冠心病科住院的30-75岁急性冠脉综合征患者。 。依诺肝素在10秒钟和30秒钟内以12小时的间隔随机注射到腹部的右侧或左侧。为了评估部位的疼痛强度,在注射之前和之后立即使用视觉模拟量表(VAS)。数据分析通过描述性统计和非参数检验完成。结果:结果表明,10秒前的疼痛强度平均值为0.78±4.93,10秒后为15.95±19.43,30秒前为0.64±3.79,30秒后为8.08±12.91。因此,注射30秒持续时间可显着降低疼痛强度(P = 0.000)。结论:根据研究结果,将皮下依诺肝素注射时间延长至30秒可降低部位疼痛强度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号